Roferon (rIFN-α2a) Is More Immunogenic Than Intron A (rIFN-α2b) in Patients with Chronic Myelogenous Leukemia
- 1 August 1994
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Journal of Interferon Research
- Vol. 14 (4) , 217-219
- https://doi.org/10.1089/jir.1994.14.217
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Distribution of Interferon-α2 Genes in HumansJournal of Interferon Research, 1994
- Effective natural interferon-alpha therapy in recombinant interferon- alpha-resistant patients with hairy cell leukemiaBlood, 1991
- Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosisThe American Journal of Medicine, 1989
- Treatment of Malignant Carcinoid Tumors With Recombinant Interferon alfa-2b: Development of Neutralizing Interferon Antibodies and Possible Loss of Antitumor ActivityJNCI Journal of the National Cancer Institute, 1989
- Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemiaBlood, 1983